Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cortesi

Showing results (141-150 of 181) with videos related to

Pageof 19
Sort By:
Cancers|March 6, 2019
Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of <i>BRCA1/2</i> Variants of Uncertain SignificanceElisa Gelli, Mara Colombo, Anna Maria Pinto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2019
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial NeoplasiaAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Breast (Edinburgh, Scotland)|February 20, 2024
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast studyGilles Freyer, Noelia Martinez-Jañez, Bożena Kukielka-Budny, et al.
Endocrine Connections|July 24, 2019
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer riskPiera Rizzolo, Valentina Silvestri, Virginia Valentini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled AnalysisSara Gandini, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
International Journal of Cancer|January 8, 2019
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in ItalyPiera Rizzolo, Veronica Zelli, Valentina Silvestri, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2015
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in ItalyValentina Silvestri, Piera Rizzolo, Marco Scarnò, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2023
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control studyAgostino Bucalo, Giulia Conti, Virginia Valentini, et al.
Tumori|June 6, 2015
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrenceGiuseppe Bogina, Gianluigi Lunardi, Francesca Coati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2023
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 StudyMatteo Lazzeroni, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Pageof 19

Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Cancers|March 6, 2019
Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of <i>BRCA1/2</i> Variants of Uncertain SignificanceElisa Gelli, Mara Colombo, Anna Maria Pinto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2019
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial NeoplasiaAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Breast (Edinburgh, Scotland)|February 20, 2024
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast studyGilles Freyer, Noelia Martinez-Jañez, Bożena Kukielka-Budny, et al.
Endocrine Connections|July 24, 2019
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer riskPiera Rizzolo, Valentina Silvestri, Virginia Valentini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled AnalysisSara Gandini, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
International Journal of Cancer|January 8, 2019
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in ItalyPiera Rizzolo, Veronica Zelli, Valentina Silvestri, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2015
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in ItalyValentina Silvestri, Piera Rizzolo, Marco Scarnò, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2023
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control studyAgostino Bucalo, Giulia Conti, Virginia Valentini, et al.
Tumori|June 6, 2015
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrenceGiuseppe Bogina, Gianluigi Lunardi, Francesca Coati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2023
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 StudyMatteo Lazzeroni, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.
Pageof 19